Abstract
Diseases involving the articular cartilage are one of the leading causes of physical impairment among the adult population. While surgical technique and advancement have allowed us effective means at treating these diseases, this is not without significant risk and morbidity. With a very solid safety profile, viscosupplementation with hyaluronic acid (HA) derivatives has become an excellent modality for treating diseased articular cartilage. Recent literature supports the use of HA not only in the management of the pain associated with osteoarthritis but also as a disease-modifying agent as well. Further studies have started to define exciting new roles for viscosupplementation in the treatment for acute injuries to the joint microenvironment.
Similar content being viewed by others
References
Ayral X (2001) Injections in the treatment of osteoarthritis. Best Prac Res Clin Rheumatol 15:609–626
Tehranzadeh J, Booya F, Root J (2005) Cartilage metabolism in osteoarthritis and the influence of viscosupplementation and steroid: a review. Acta Radiol 3:288–296
Lo G, Michael L, McAlindon T (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290(23):3115–3121
Watterson JR, Esdaile JM (2000) Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg. 8(5):277–284
Moreland LW (2003) Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 5(2):54–67
Buckwalter JA, Saltzman C, Brown T (2004) The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 427(suppl):S6–S15
(2007) Physicians desk reference, 61st edn. Thomson PDR, Montvale
Goldberg VM, Buckwalter JA (2005) Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarth Cartil 13(3):216–224
Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL, Bailleul F, Pavelka K (2010) Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 69(1):113–119
Conrozier T, Jerosch J, Beks P, Kemper F, Euller-Ziegler L, Bailleul F, Chevalier X (2009) Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study. Arch Orthop Trauma Surg 129(3):417–423
Puhl W, Bernau A, Greiling H et al (1993) Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthr Cartil 1(4):233–241
Bellamy N, Campbell J, Robinson V et al. (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev CD005321
Richmond J, Hunter D, Irrgang J et al (2009) American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee (nonarthroplasty). J Am Acad Orthop Surg 17(9):591–600
Wang CT, Lin J, Chang CJ, Lin YT, Hou SM (2004) Therapeutic effects of hyaluroinc acid on osteoarthritis of the knee: a meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A:538–545
Altman RD, Moskowitz R (1999) Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 26(5):1216
Sen C, Gunes T, Saygi B et al (2008) The chondroprotective effect of intra-articular hyaluronic acid at early stages of osteoarthritis: an experimental study in rabbits. Acta Orthop Traumatol Turc 38(5):348–352
Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Treves R, Vignon E, Chevalier X (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol 21(5):605–610
Sun SF, Chou YJ, Hsu CW, Chen WL (2009) Hyaluronic acid as a treatment for ankle osteoarthritis. Curr Rev Musculoskelet Med 2(2):78–82
Blaine T, Moskowitz R, Udell J, Skyhar M, Levin R, Friedlander J, Daley M, Altman R (2008) Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 90(5):970–979
Kaplan LD, Lu Y, Snitzer J, Nemke B, Hao Z, Biro S, Albiero W, Stampfli HF, Markel M, Popkin C, Baum SZ (2009) The effect of early hyaluronic acid delivery on the development of an acute articular cartilage lesion in a sheep model. Am J Sports Med 37(12):2323–2327
Sonoda M, Harwood FL, Amiel ME, Moriya H, Temple M, Chang DG, Lottman LM, Sah RL, Amiel D (2000) The effects of hyaluronan on tissue healing after meniscus injury and repair in a rabbit model. Am J Sports Med 28(1):90–97
Hempfling H (2007) Intra-articular hyaluronic acid after knee arthroscopy: a two-year study. Knee Surg Sports Traumatol Arthrosc 15(5):537–546
Huang MH, Yang RC, Chou PH (2007) Preliminary effects of hyaluronic acid on early rehabilitation of patients with isolated anterior cruciate ligament reconstruction. Clin J Sport Med 17(4):242–250
Yagishita K, Sekiya I, Sakaguchi Y et al (2005) The effect of hyaluronan on tendon healing in rabbits. Arthroscopy 21(11):1330–1336
Shikhman AR, Kuhn K, Alaaeddine N, Lutz M (2001) N-acetylglucosamine prevents IL1 mediated activation of human chondrocytes. J Immunol 166:5155–5160
Shikhman AR, Amiel D, Lima DD, Hwung SB, Hu C, Xu A, Hashimoto S, Kobayashi K, Sasho T, Lotz MK (2005) Chondroprotective activity of N-Acetylglucosamine in rabbits with experimental osteoarthritis. Ann Rheum Dis 64:89–94
Campo GM, Avenoso A, Campo S, Ferlazzo AM, Altavilla D, Calatroni A (2003) Efficacy of treatment with glucosaminoglycans on experimental collagen induced arthritis in rats. Arthritis Res Ther 5:R122–R131
Sabaratnam S, Coleman PJ, Badrick E, Mason RM, Levick JR (2002) Interactive effect of chondroitin sulphate C and hyaluronan on fluid movement across rabbit synovium. J Physiol 540(1):271–284
Frisbie DD, Kawcak CE, Mcllwraith CW, Werpy NM (2009) Evaluation of polysulfated glucosaminoglycans or sodium hyaluronan administered intraarticularly for treatment of horses with experimentally induced osteoarthritis. Am J Vet Res 70:203–209
Conflict of interest
The authors declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clegg, T.E., Caborn, D. & Mauffrey, C. Viscosupplementation with hyaluronic acid in the treatment for cartilage lesions: a review of current evidence and future directions. Eur J Orthop Surg Traumatol 23, 119–124 (2013). https://doi.org/10.1007/s00590-012-0940-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-012-0940-0